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ABSTRACT: The synthetic biology toolkit contains a
growing number of parts for regulating transcription and
translation, but very few that can be used to control protein
association. Here we report characterization of 22 previously
published heterospecific synthetic coiled-coil peptides called
SYNZIPs. We present biophysical analysis of the oligomeriza-
tion states, helix orientations, and affinities of 27 SYNZIP
pairs. SYNZIP pairs were also tested for interaction in two cell-
based assays. In a yeast two-hybrid screen, >85% of 253
comparable interactions were consistent with prior in vitro
measurements made using coiled-coil microarrays. In a yeast-
signaling assay controlled by coiled-coil mediated scaffolding,
12 SYNZIP pairs were successfully used to down-regulate the expression of a reporter gene following treatment with α-factor.
Characterization of these interaction modules dramatically increases the number of available protein interaction parts for
synthetic biology and should facilitate a wide range of molecular engineering applications. Summary characteristics of 27 SYNZIP
peptide pairs are reported in specification sheets available in the Supporting Information and at the SYNZIP Web site [http://
keatingweb.mit.edu/SYNZIP/].
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T
he central goal in synthetic biology is to engineer living
systems that exhibit new behaviors and functions. The
most common approach is to start with a set of standard
biological parts or modules and to combine them in new ways
to give rise to desired properties. To design increasingly
complex systems, larger sets of characterized parts are required.
Several groups have addressed the challenge of refining and
standardizing biological parts and devices by assessing the
activity of different promoters in cell-based transcriptional
assays, designing synthetic ribosome binding sites, engineering
directed transcript cleavage by RNase, creating libraries of
simple logic gates, and constructing orthogonal bacterial
expression systems.
1−8 These studies have generated diverse,
well-defined modules, and collections of many well-charac-
terized molecular components can be found in the Registry of
Standardized Parts (http://partsregistry.org/) and at BioFAB
(http://www.biofab.org/). Most of the parts currently used for
biological design are directed toward regulation at the level of
transcription or translation, and the set of reagents available for
post-translational control is limited. A small number of protein
interaction domains, including coiled coils, PDZ, SH3, and
GBD domains, have been used to localize or oligomerize
proteins. These have been applied in both scaffolding and
signaling applications with impressive results,
9−11 but the
limited number and diversity of well-characterized domains
restricts the complexity that can be designed. A larger repertoire
of interaction reagents could facilitate the implementation of
more complex systems.
Coiled coils, structures in which α helices intertwine to form
superhelical bundles, are the simplest of all protein interaction
motifs and have a rich history of use in molecular engineering.
Coiled coils of only ∼20−50 residues can fold and oligomerize
into homo- or heteromeric 2-to-4 helix bundles,
12 and many of
the sequence features that govern coiled-coil interaction
specificity are known.
13−15 Coiled-coil sequences have a
repeating seven-residue pattern, termed a heptad repeat, that
is denoted (abcdefg)n. Hydrophobic residues occupy many of
the a and d positions, forming a well packed interface, and e and
g positions on opposing helices tend to be electrostatically
complementary. Homodimerizing coiled coils have been used
to stabilize complexes,
16−20 study self-assembly,
21 and dimerize
artificial transcription factors.
22−24 Beyond using protein
interactions for self-oligomerization, heterodimerizing coiled
coils allow the creation of more complex systems by bringing
different components together. Recent studies have applied
coiled-coil heterodimers to nanofiber formation
25−27 three-
dimensional organization of nanoscale particles,
28 the engineer-
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29 and signaling pathway
modulation via recruitment of kinases/phosphatases.
9 These
studies indicate there is a promising future in using coiled-coil
reagents in biomolecular engineering, one limitation being the
small number of interacting partners to choose from.
Reinke et al. recently reported a set of 23 synthetic
heteroassociating coiled coils called SYNZIPs.
30 The SYNZIPs
were originally designed to interact heterospecifically with the
leucine-zipper regions of human bZIP transcription factors as
parallel coiled-coil dimers and in this context were referred to
as anti-bZIPs.
31 Following assessment of the interaction of the
anti-bZIPs with their human protein targets,
31 the designed
proteins were tested for pairwise interactions among themselves
using a coiled-coil microarray assay.
30 Twenty-three peptides
Figure 1. Biophysical properties of SYNZIPs. (a) SEC elution traces. The left panel shows SYNZIP1 in green, SYNZIP2 in blue, the
SYNZIP1:SYNZIP2 mixture in red, and the GCN4-pIqI trimer control in black. The right panel shows SYNZIP21 in blue, SYNZIP19 in green, the
SYNZIP19:SYNZIP21 mixture in red, and the GCN4-pIqI trimer control in black. (b) The cartoon shows a schematic of the FRET assay, and the
bar graph shows FRET efficiencies for selected pairs. Hatched bars are the N-terminal donor/N-terminal acceptor mixes, and gray bars are the C-
terminal donor/N-terminal acceptor mixes. (c) Representative FP titrations plotted as the fraction of the fluorescein labeled protein bound. Each
plot shows reciprocal measurements, with each interaction partner used in turn as the labeled species. Raw data, showing millipolarization, is
available in Supplementary Figure 3. (d) Competition between strong and weak SYNZIP pairs. Observed interactions are summarized in graphs at
the top of each plot, where circles represent SYNZIPs, bold lines indicate strong interactions, and dotted lines indicate weak interactions observedi n
this assay. The fluorescence polarization of different mixtures is shown in the bar graphs. “F” and “R” in the legend of each plot designates the species
labeled with fluorescein or rhodamine, and the curves show the best fit to the data (see Methods). Error bars show ±1 SD over three (b and c) or
four (d) replicates.
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modules on the basis of minimal self-interaction and strong
heteroassociation with one or more of the other designs. These
23 anti-bZIP peptides were renamed SYNZIPs. Comprehensive
analysis of pairwise SYNZIP interactions revealed many
interesting network patterns, such as orthogonal interaction
pairs and hub-spoke motifs. Crystallographic studies of 2 of the
interacting pairs, SYNZIP1:SYNZIP2 and SYNZIP5:SYNZIP6,
demonstrated that these form parallel, dimeric coiled coils.
30
Although in vitro array studies have established that many
SYNZIP pairs form tight, heterospecific complexes, more
information about their interaction properties is required if they
are to be employed as standard molecular interaction parts.
Furthermore, SYNZIP interactions have yet to be validated
inside cells. To facilitate the use of these modules for diverse
purposes, we here present extensive biophysical character-
ization of numerous SYNZIP interactions in vitro and report the
ability of many pairs to interact with the anticipated specificity
in yeast.
Table 1. SYNZIP Pair Biophysical Properties
SYNZIP interaction
a oligomerization
b orientation
c av Kd
d
1 off monomer n/a n/a
2 off monomer n/a n/a
3 off monomer n/a n/a
4 off monomer n/a n/a
5 off monomer n/a n/a
6 off monomer n/a n/a
11 off monomer n/a n/a
14 self-interaction dimer not determined inconclusive
16 self-interaction dimer not determined inconclusive
17 off inconclusive n/a n/a
18 off monomer n/a n/a
19 off monomer n/a n/a
20 self-interaction dimer not determined inconclusive
21 self-interaction dimer not determined inconclusive
1 + 2 on dimer parallel <10
2 + 14 on dimer parallel <10
2 + 19 on dimer parallel <10
2 + 20 on dimer parallel <10
3 + 4 on dimer parallel <30
3 + 5 weak no interaction n/a >400
e
4 + 6 weak no interaction n/a >400
e
4 + 21 on dimer parallel <10
5 + 6 on dimer parallel <15
5 + 16 on dimer parallel <10
5 + 18 weak no interaction n/a >200
e
5 + 21 on dimer parallel <10
6 + 19 on dimer parallel <10
6 + 20 on dimer
f parallel <10
6 + 21 weak multiple species n/a >200
e
11 + 18 off no interaction n/a not determined
11 + 19 on dimer parallel <10
11 + 20 on dimer parallel <10
11 + 21 on dimer
f parallel <10
14 + 17 on dimer parallel <10
14 + 21 on dimer
g parallel <10
16 + 19 on dimer parallel <10
16 + 20 on dimer
g parallel <10
16 + 21 on dimer
g parallel <10
17 + 18 on dimer antiparallel <10
17 + 21 on dimer parallel <10
18 + 19 on dimer parallel <10
18 + 20 on dimer parallel <15
18 + 21 weak no interaction n/a >300
e
19 + 20 off not tested n/a not detected
19 + 21 on dimer parallel <10
20 + 21 on dimer
g parallel <10
aDetermined from the SEC, FRET, and FP data.
bDetermined by SEC.
cDetermined by FRET.
dFrom best fit, or average of the two best-fit Kd
values when each species was labeled for the assay.
eNo upper baseline was obtained in the assay.
fElution trace with a leading edge slightly larger
than dimer.
gMixture of two homo-oligomerizing species.
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Maximal utility of the SYNZIPs, for applications in molecular
engineering, demands knowledge of their interaction geo-
metries and affinities. Although the SYNZIPs share many
sequence features in common with bZIP leucine zippers, which
form parallel coiled-coil dimers to allow the transcription
factors to bind DNA, it has also been observed that even a
single amino-acid change can alter the oligomerization state or
helix orientation of coiled coils.
32−34 Crystal structures of two
SYNZIP complexes revealed that these form parallel hetero-
dimers, and Reinke et al. further argued that many other
SYNZIP pairs are likely to do so.
30 However, establishing this
experimentally requires extensive biophysical characterization,
which we report here.
For synthetic biology applications, SYNZIPs must form the
expected interactions in cells when fused to a variety of
domains. To test whether SYNZIPs expressed as fusion
proteins can interact similarly to shorter coiled-coil peptides,
we carried out in vitro studies using MBP fusions. We chose 14
SYNZIPs for in vitro testing, selecting proteins that had many
interaction partners in the prior coiled-coil microarray tests or
that interacted with a SYNZIP that had many interaction
partners. We also tested SYNZIP fusions for function in cells,
assaying 22 SYNZIPs as Gal4 DNA-binding and activation-
domain constructs in a two-hybrid screen and 14 SYNZIPs as
Msg5- and Ste5-fusions in a MAPK signaling assay.
SYNZIP Oligomerization State. Oligomerization state is a
critical parameter for interaction reagents. For example, it was
recently demonstrated that varying the number of protein
interaction sites on a synthetic scaffold can tune the output of
synthetic metabolic pathways.
10,11 Thus, we developed a
moderate-throughput strategy to assess the oligomerization
state of numerous SYNZIPs and SYNZIP complexes.
SYNZIPs have a molecular weight of ∼5 kDa, which is one of
their advantages as interaction modules. Their small size
precludes easy determination of oligomer state using size
exclusion chromatography (SEC), but using MBP fusion
proteins allowed us to separate oligomers based on molecular
weight changes of ∼50 kDa, which corresponds to a significant
difference in hydrodynamic radius. Interacting SYNZIP-MBP
fusions are composed of two globular domains attached to a
rigid coiled-coil linker, and this unusual shape could potentially
influence their elution profiles. Thus, we used the SYNZIP1:-
SYNZIP2 heterodimer with each peptide fused to MBP as a
dimer standard
31 and made a homotrimeric mutant of the yeast
bZIP GCN4, GCN4-pIqI
35 fused to MBP as a trimer standard.
SEC results for SYNZIP1:SYNZIP2 and SYNZIP19:SYN-
ZIP21 are shown in Figure 1a, and results for all other tested
pairs are summarized in Table 1 and detailed in the Supporting
Information. The majority of individual SYNZIPs eluted as
monomers, as expected in the absence of a heterodimerization
partner, but there were exceptions. Several constructs eluted
later than most monomers and/or had asymmetric tailing peaks
(Figure 1a, Supplementary Data 1). It is not unexpected that
SYNZIP monomers would have some affinity for the column
matrix, as leucine-zipper monomers are mostly unfolded and
expose many hydrophobic residues. The degree of residual
structure in SYNZIP monomers could also vary with sequence.
Several zippers that appeared to form homo-oligomers at 10
μM injection concentrations were further tested for self-
association using fluorescence polarization at lower concen-
trations (see below).
In cases where the individual zippers eluted as monomers, it
was very clear when a dimer formed upon mixing because there
was a shift of almost all protein to a dimer peak. For example, in
Figure 1a, the left panel shows the elution profiles of SYNZIPs
1 and 2. SYNZIP1 eluted primarily in a peak at the size
expected for a monomer. Most of SYNZIP2 eluted slightly later
than observed for other monomers. The SYNZIP1:SYNZIP2
mixture gave a strong peak in the dimer size range. SEC could
also be used to detect cases where a monomeric species was
m i x e dw i t hah o m o - o l i g o m e rizing partner, forming a
preferential heterodimer. For example, SYNZIP21 alone eluted
as a dimer, and SYNZIP19 eluted later than most monomers. It
was nevertheless clear that a dimeric complex was formed by
the mixture, because monomeric species all but disappeared
from the elution profile and instead most of the protein eluted
in the dimer-size peak (Figure 1a, right panel). When two
homodimerizing SYNZIPs were mixed and gave a large peak at
the expected dimer elution volume, the SEC data could not be
used to confirm interaction. Nevertheless, such experiments
supported the formation of dimers rather than higher order
species, and pairs showing this behavior (e.g., SYNZIP14:SYN-
ZIP21, Supplementary Data 1) were further characterized using
orientation and affinity assays (Table 1).
SYNZIP Interaction Orientation. Although certain
sequence features suggest a parallel arrangement of SYNZIP
helices,
30 we sought to confirm this experimentally because
knowing the interaction geometry can be critical for molecular
engineering. For example, knowledge of helix orientation was
necessary in the design of artificial transcription factors using
coiled coils fused to DNA binding domains, as demonstrated
with zinc fingers
23 and polyamides.
24
To determine the interaction orientation of SYNZIP helices,
we employed a FRET assay in which the first partner was
labeled with a fluorescein donor on either the N- or C-
terminus, and the second partner was N-terminally labeled with
a rhodamine acceptor (Figure 1b). In a parallel complex, an N-
terminal fluorescein will exhibit greater FRET efficiency than a
C-terminal fluorescein when transferring energy to a rhodamine
acceptor conjugated to the N-terminus of an interaction
partner. An antiparallel interaction would exhibit greater FRET
efficiency when a C-terminal fluoresceinated peptide was mixed
with an N-terminal acceptor. Because this is a population assay,
it reports only the prevailing helix orientation, and thus it is
possible that mixtures of orientations are present in some cases.
The crystal structures of the SYNZIP1:SYNZIP2 and
SYNZIP5:SYNZIP6 pairs confirm a parallel orientation for
these complexes, so these were used as parallel controls. The
coiled-coil Acid-a1/Base-a1 was used as an antiparallel control
34
(Figure 1b).
For all but one of the SYNZIP interactions measured, we
observed a greater FRET efficiency for the N-donor/N-
acceptor mix than for the C-donor/N-acceptor mix, supporting
a predominantly parallel helix orientation (Table 1). This was
true regardless of which peptide was labeled with fluorescein
and which was labeled with rhodamine; each complex was
tested using both combinations (Supplementary Data 1). When
we tested the SYNZIP6:SYNZIP21 pair that did not interact on
the peptide microarrays or by SEC, no FRET signal was
observed. Figure 1B shows differences in FRET efficiencies for
4 parallel SYNZIP pairs. SYNZIP17:SYNZIP18 gave the
opposite pattern, indicating an antiparallel interaction similar
to the antiparallel control pair Acid-a1/Base-a1 (denoted Facid
+ Rbase in Figure 1b). This pair eluted as a dimer in SEC,
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heterodimer. Manual inspection of the sequences of SYNZIPs
17 and 18, as they would interact in an antiparallel heterodimer,
suggests two possible alignments that maximize the helix−helix
overlap and predict electrostatic complementary at adjacent
interfacial e and g positions (Supplementary Data 1).
SYNZIP Interaction Affinities. Knowledge of the affinities
of SYNZIP complexes is necessary for determining the
concentration range at which they will be effective interaction
reagents. It has also been demonstrated that changing the
affinity of a coiled-coil interaction in a MAPK signaling assay
can tune the effect of a modulator and create complex pathway
responses.
9 We assayed 27 SYNZIP pairs using a fluorescence
polarization (FP) assay in which fluoresceinated MBP-fusion
SYNZIP was mixed with increasing concentrations of an
unlabeled MBP-fusion partner.
The majority of SYNZIP interacting pairs tested were very
stable, with dissociation constants less than 10 nM (Figure 1).
Quantifying affinities tighter than this is beyond the sensitivity
of the assay. Thus the reported Kd values for tight binders can
be considered an upper limit. Overall, the affinity data agree
well with data from other assays. Strong hetero interactions
detected in the previous coiled-coil array study
30 and by SEC all
had very tight affinities as measured by FP. For weakly
interacting pairs, i.e., those not previously observed to interact
and those that interacted only weakly on protein microarrays,
interactions were observed only at higher concentrations, if at
all, and we could not detect an upper baseline even at
concentrations approaching 20 μM (Supplementary Data 1 and
Figure 1). Finally, most of the self-interactions originally
detected by SEC exhibited a slow increase in polarization with
increasing concentration, inconsistent with cooperative two-
state binding (Supplementary Figure 2). Figure 1c shows
titration binding curves for three tight SYNZIP interactions and
one weak interaction.
We also tested whether a tight pair could compete effectively
with a weak pair. For example, the SYNZIP18:SYNZIP21 pair
showed no signal on the coiled-coil microarrays
30 and showed
weak interaction in FP studies (Kd > 250 nM). When
SYNZIP18 labeled with fluorescein was mixed with a high
concentration of SYNZIP21, we detected an interaction
between the two as indicated by an increase in polarization.
Figure 2. SYNZIP interactions detected by Y2H. (a) Histidine selection with 100 mM 3-AT, 12 days growth, represented in greyscale with white as
no growth and black as strongest growth. (b) Heat map comparing Y2H data with coiled-coil microarray data, with Y2H in the lower left and
microarray in the upper right. Red ×'s indicate an interaction observed in Y2H but not seen on the microarray or vice versa. Y2H data is shown as
black, strong interaction; gray, undetermined interaction; white, no interaction; blue, two autoactivators (see Methods). Microarray data is the
maximum of the two reciprocal measurements ranging from no interaction (white, arrayscore > 1) to strong interaction (black, arrayscore = 0).
30 (c,
d) Uracil selection, 12 days growth and heat map comparison with microarray, as in panel b.
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forms a tight complex with SYNZIP21, was included in the
mixture, the weak interaction no longer occurred (Figure 1d).
Similar trends were observed for other pairs, as shown in Figure
1d.
SYNZIP Interactions in a Yeast Two-Hybrid Assay. The
yeast two-hybrid (Y2H) assay provides a straightforward and
widely used way to assess the ability of SYNZIPs to mediate
protein association in cells.
36−39 The proteins to be tested are
individually fused to the DNA-binding (bait) and activation
domains (prey) of the Gal4 transcription factor. In our version
of the assay, a SYNZIP−SYNZIP interaction reconstitutes the
transcription factor, which then drives expression of URA3 and
HIS3 reporter genes. A positive readout requires that the fusion
proteins be expressed, localize to the nuclei of living cells, and
interact. Thus, Y2H can be used to determine whether SYNZIP
fusions are toxic to cells, and whether concentrating them in
the nucleus affects their interaction behavior.
We tested all pairwise combinations of 22 SYNZIPs both as
DNA-binding and activation domain fusions for both selection
assays. Figure 2a and c summarizes our observations that many
SYNZIP pairs did not support growth, as expected, and that
rapidly growing colonies were often detected reciprocally in
both fusion contexts. For all of the SYNZIPs in each fusion
context, we observed comparable growth rates on selection
media for plasmid maintenance only, indicating that con-
stitutive expression of these SYNZIP fusion constructs had no
noticeable effect on cell viability. There were 3 autoactivating
DNA-binding domain fusions (SYNZIPs 4, 11 and 18) that
permitted growth alone and regardless of partner. We did not
observe any autoactivating activation-domain fusions, indicating
that the SYNZIPs did not directly bind the promoters of the
reporters in this system. The Y2H assay showed good overall
agreement with interaction profiles observed in previous work
using coiled-coil microarrays.
30 On the basis of comparisons of
235 pairs (see Methods) under -histidine selection, 12 strong
interactions observed by Y2H were not seen on the arrays and
12 strong array interactions were not detected by Y2H, for an
overall discrepancy of ∼10% (Figure 2b). The -uracil selection
data allowed us to compare 237 pairs, and we found that 7
strong interactions observed by Y2H were not seen on the
arrays, and 23 strong array interactions were not detected by
Y2H, for an overall discrepancy of ∼13% (Figure 2d). We
observed several interactions involving SYNZIP8 that were not
detected in the original study, including pairs 8:2, 8:14, and
8:21. We also did not see a previously strong interaction
between SYNZIPs 13 and 15, although this interaction was
detected in the MAPK assay described below. These results
indicate that many of the SYNZIP pairs can function as general
interaction reagents in a yeast nuclear context. The full data sets
are available in Supplementary Data 3.
Repressing Yeast α-Factor Response Using SYNZIPs
as Recruitment Domains for a Negative Pathway
Modulator. Bashor et al. recently demonstrated how the
output of the yeast mating pathway can be modulated by
recruiting kinases or phosphatases to the protein scaffold Ste5
in the yeast cytoplasm.
9 A heterodimeric variant of a native
bZIP protein dimerization domain was used in the original
application.
15 In our version of this assay, one SYNZIP was
fused to the Ste5 scaffold to provide a binding site for a second
SYNZIP that was fused to the phosphatase Msg5 (Figure 3,
inset). The effect of recruiting Msg5 to Ste5 on the mating
response was detected using a GFP reporter gene. Following α-
factor induction of the MAPK signaling cascade, we expected
Figure 3. Cell fluorescence as a measure of MAPK pathway modulation by SYNZIP pairs. SYNZIP pairs are rank ordered, left-to-right, by the
relative mean cell fluorescence induced when the pair was used to recruit Msg5 to Ste5 (inset). The first SYNZIP listed was fused to the Ste5 scaffold
protein and the second was fused to Msg5 phosphatase. Green bars indicate interacting pairs as determined by Y2H and coiled-coil microarray. Two
instances where SYNZIPs that interacted on the array showed little MAPK pathway down-regulation are highlighted in yellow. Average signals from
4 replicates are reported relative to the average signal for a Ste5-SYNZIPX:Msg5-nozipper control, with X the corresponding SYNZIP for the Ste5
fusion. Error bars show 1 SD of 4 measurements.
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reporter activation compared to a control in which Msg5 was
not fused to any SYNZIP. We tested 13 pairs expected to
interact and 29 pairs expected not to interact on the basis of
prior studies.
Figure 3 shows the normalized mean fluorescence intensity
of GFP in cells 120 min after α-factor induction (raw data
available in Supplementary Data 4). Tested pairs are ordered
from those that gave the lowest GFP expression, at left, to those
that gave the highest GFP expression at right. Those pairs
observed to interact on coiled-coil microarrays are show in
green, and these gave the most reduced pathway outputs, as
expected. Two exceptions where expected interactions did not
lead to transcriptional down-regulation are shown in yellow.
For example, the SYNZIP2:SYNZIP13 interaction was very
strong on the coiled-coil arrays and in the Y2H -histidine
Figure 4. SYNZIP interaction specification sheet for pair SYNZIP1:SYNZIP2.
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that in one fusion context the SYNZIP6:SYNZIP20 pair, a
strong interaction in our other assays, had less effect than some
of the weak or undetected pairs. Weak SYNZIP pairs and self-
interactions, shown in blue, had less effect on pathway output
than tight pairs, as expected. The SYNZIP18:SYNZIP21 pair
gave a moderate response in the scaffolding assay, although it
was not detected using microarrays, in Y2H or by SEC, and
gave a Kd of >250 nM by the FP assay (Supplementary Data 1).
The few differences in activity observed between the scaffolding
assay and Y2H are not unexpected, as the interactions are being
tested in different cellular environments and at different
concentrations. Overall, the MAPK signaling data indicate
that many SYNZIPs can interact in a cytosolic environment,
with low to moderate expression levels, while maintaining the
specificity of the interactions.
SYNZIP Specification Sheets. Multifaceted character-
ization of SYNZIP interactions has allowed us to compile
detailed biological specification sheets for 27 SYNZIP pairs
(Supplementary Data 1). Figure 4 shows a specification sheet
for the SYNZIP1:SYNZIP2 pair. For this pair, we present the
sequence alignment of the interaction based on the crystal
structure, although in most cases we present a probable
alignment based on electrostatic complementary at e−g′
positions and other specificity determinants such Asn-Asn
pairing at a-a′ positions
40 (primes indicate a position on the
opposite helix). Next, a table summarizes all of the interaction
data we collected, including experimental observations and
additional comments. The original protein microarray data are
presented using arrayscore values, as defined in ref 30, where
numbers approaching zero indicate strong binding. Yeast two-
hybrid data are reported qualitatively, and increasing numbers
of “+” symbols indicate larger yeast colonies for interacting
SYNZIP pairs. Instances of non-reciprocal interactions with
respect to DNA-binding versus activation-domain fusions and
instances of autoactivation are noted. The α-factor MAPK
repression is reported as the fractional repression of pathway
output in each fusion context. The coiled-coil oligomerization
state, helix orientation, and Kd based on the SEC, FRET, and
FP assays are reported, with notes advising of any deviations
from ideal behavior in the assays. We also present data for the
biophysical assays, interactions with other SYNZIPs detected in
any assays, constructs that are available, any associated PDB
codes, and other comments. The SYNZIP specification sheets
are intended to facilitate use of these reagents in a variety of
molecular engineering applications.
Discussion. Several properties of the SYNZIPs suggest they
will find utility as reagents in synthetic biology, nano-
technology, and other fields. First, the SYNZIPs predominately
form high-affinity dimers, indicating they can be used for the
stoichiometic assembly of fusion partners. Recent reports
describe several orthogonal protein interaction domains that
can be used for multiple recruitments events; however there is a
limitation in the number of such pairs available. Furthermore,
the affinities of the several common reagents in use, PDZ, SH3,
and GBD domains, are in the upper nanomolar to lower
micromolar range.
10,11 SYNZIPs could provide additional
orthogonal interaction pairs, but with much higher affinity,
allowing recruitment at lower expression levels. Next, for all but
one of the tested pairs, our assays indicate that parallel
assemblies are forming, providing a common structure for
modular design. At the same time, the one instance of an
antiparallel coiled coil (SYNZIP17:18) could also be useful; we
are exploring the design of additional antiparallel components.
Finally, tight and weak pairs have large affinity gaps and high
heterospecificity. Affinity differences could allow competitive
displacement strategies, where a weakly interacting partner is
displaced by a stronger one, as shown in several examples in
Figure 1d. Although we have only put an upper bound on the
Kd's of most interacting SYNZIP pairs, there are likely to be
differences among these affinities, and competitive displace-
ment may be possible in this regime as well. Alternatively,
overexpression of one partner with respect to another could
lead to partner switching. Characterizing the kinetics of
exchange in future work will be important for developing
displacement as a design feature.
A unique feature of the SYNZIPS, compared to interaction
modules such as PDZ, SH3, and GBD domains, is that they can
form combinatorial pairwise interactions and thus provide
access to rich sets of network motifs. To facilitate visualization
and selection of such motifs, we have provided several
interaction data sets in a format easily readable by Cytoscape,
41
including two sets of yeast two-hybrid data (using 2 different
reporters) and the protein microarray arrayscores from the
previously published work (Supplementary Data 5). Here we
discuss several sets of the best characterized SYNZIPs that can
be used to construct interesting and potentially useful network
motifs.
Linear Interactions: SYNZIPs 2:19:21:4. One type of
interaction network that we see among the SYNZIPs has a
linear topology (Figure 5a). In this type of motif, two
interacting pairs (2:19 and 21:4) share an interaction between
them (19:21). Although these interactions are very tight, one
could imagine their use in competition experiments using
stoichiometric variations. For example, a desired final state of
an interaction between 2 and 19 could be inhibited by a higher
amount of 21 sequestering 19. The interactions could then be
switched in the presence of an excess of 4, which would bind
21, thus freeing 19 and allowing the desired final state. The off
rates for several leucine zippers are in the range 10−2 to 10−4
s−1, indicating that such a competition strategy could be
reasonable.
42−44
Ring Interactions: SYNZIPs 18:19:21:20. A second type of
interaction network has a ring topology (Figure 5b). This motif
has strong interactions among 4 SYNZIPs that make up the
perimeter of a ring, with a much lower affinity interaction
between 18 and 21 and no interaction observed between 19
Figure 5. Network motifs constructed from SYNZIP pair interactions:
(a) linear, (b) ring, (c) hub, and (d) orthogonal-pair motifs. Proteins
are denoted as circles, with the SYNZIP number indicated. Strong
interactions are shown with solid lines, and weak interactions with
dashed lines. SYNZIPs that are not connected by an edge did not
interact in the Y2H or previous coiled-coil microarray assays. All
interactions and some non-interactions were confirmed in vitro in this
work. The asterisk indicates an antiparallel interaction between
SYNZIP17 and SYNZIP18.
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binding partners, cross-reactivity of 18 and 21 is minimized
(Figure 1d). This type of interaction could be used in a single-
SYNZIP recruitment/single-SYNZIP competition arrangement,
i.e., SYNZIP19 could be used to recruit both 18 and 21, and
overexpression of SYNZIP20 would competitively eliminate
both interactions with 19.
Hub Interactions: SYNZIPs 17:18:19:20. A hub interaction
motif can be formed by removing SYNZIP21 from the
previously described ring motif and adding SYNZIP17 (Figure
5c). An interesting property of this interaction set is the
inclusion of an antiparallel partner. One could imagine an
application of this motif as a way to localize several proteins,
using just one recruitment domain. For example, the hub
partner 18 could be fused to a cellular membrane protein that is
expressed at high levels. If expressed at lower levels, the
remaining SYNZIPs could all be localized to the membrane.
Orthogonal Interactions: SYNZIPs 1:2, 3:4. Finally, the lack
of interactions among several SYNZIPs provides orthogonal
pair motifs (Figure 5d). These interactions allow multiple
interaction events to be insulated from each other. Many
applications for this type of motif can be envisioned, e.g.,
partners from multiple orthogonal pairs could be linked
together and used as a fully synthetic scaffold, or multiple
pathways could be modulated by recruitment events with
minimal crosstalk.
We would like to emphasize that these network motifs are
inferred from interactions tested in 2-component mixtures.
With some exceptions, we have not confirmed that the
expected dimers are the primary species that form in solution
when multiple SYNZIPs are mixed. For example, it is possible
that in some combinations more than two SYNZIPs assemble
into higher order complexes. Reinke et al. showed that 4-
component mixtures (of SYNZIPs 1, 2, 3, and 4 or SYNZIPs 1,
2, 5, and 6) formed the expected pairs, implementing the
orthogonal pair-type motif shown in Figure 5d. Here we have
demonstrated that in several three-component mixtures, the
strong interaction forms preferentially over the weak interaction
(Figure 1d). It is likely, given the dimer-like sequence
characteristics of the SYNZIPs, that other SYNZIPs will form
the expected heterodimers even in complex mixtures, but for
the majority of cases this remains to be experimentally verified.
In summary, the SYNZIPs comprise a large set of well-
characterized synthetic protein interaction reagents. SYNZIPs
have properties that make them well suited for use in the design
of biological systems. They form highly specific, high affinity
interactions, allowing them to mediate interactions at low
concentrations. They are small, between 30 and 50 residues,
and should incur a small metabolic cost for the cells in which
they are used. Fusion proteins that we have made to SYNZIPs
are soluble and well behaved in vitro, and cell toxicity in E. coli
and yeast appears to be limited. Finally, SYNZIPs participate in
diverse interaction motifs, providing access to complex
connectivities that go beyond simple one-to-one interactions.
With the extensive biophysical characterization and yeast-cell
validation presented here, the SYNZIP interaction reagents
greatly increase the number of available protein−protein
interaction tools for scientists to use for engineering systems
at the post-translational level.
■ METHODS
Cloning, Purification, and Dye Labeling. Synthetic
genes encoding SYNZIPs with stop codons
30 were initially
PCR-amplified and ligated into pENTR vectors using D-TOPO
cloning (Invitrogen). Subsequent addition of N- or C-terminal
Cys-Gly residues and removal of stop codons was done by PCR
mutagenesis using the initial pENTR-SYNZIP vectors.
SYNZIPs were then recombined into appropriate destination
vectors using LR Clonase II (Invitrogen) in 5 or 2.5 μL
reactions (see Supplementary Figure 4 and Supplementary
Table 1 for constructs). Synthetic genes used for the MAPK
assay were designed with yeast optimized codons using Gene
Designer,
45 synthesized by PCR and then cloned into vectors
using standard digestion and ligation procedures. For protein
expression, SYNZIPs bearing N- or C-terminal Cys residues
were recombined into a pMAL (NEB) derivative vector
including a TEV protease cleavage site (not used) between
maltose binding protein (MBP) and the Gateway linker region,
and a C-terminal His6X. These destination vectors were
transformed into BL21(DE3) cells (Agilent). Liquid cultures
(500 mL) were induced with 1 mM IPTG at OD600 0.6 for 4 h
at 37 °C. Cells were pelleted, resuspended, and then lysed by
sonication, and proteins were purified from the supernatant
using NiNTA agarose (Qiagen) under native conditions. There
was little variation in growth rate or peptide yield among
different SYNZIPs, indicating overexpression of these fusion
constructs did not have noticeably adverse effects on the cells.
NiNTA-purified proteins were dialyzed and concentrated into
PBS (2 mM KH2PO4,1 0m MN a 2HPO4, 137 mM NaCl, 2.7
mM KCl) pH 7.4, 1 mM DTT, 37% glycerol and stored at −20
°C. Control proteins GCN4-pIqI, Acid-a1 and Base-a1 (see
below) were designed with E. coli optimized codons using DNA
Works,
46 gene synthesized by PCR, ligated into the pENTR
vector using D-TOPO cloning, recombined into the pMAL
derivative expression vector, and purified as above.
Cys-containing MBP-SYNZIP-His6X proteins were labeled
using maleimide chemistry with fluorescein-5-maleimide (N-
terminal or C-terminal) or Rhodamine Red C2 maleimide (N-
terminal only) (Invitrogen). A 50 pmol portion of protein from
glycerol stocks was reduced with 1 mM TCEP-HCl (Pierce)
and then buffer exchanged into degassed PBS. The fluorophore
was added at 10-fold molar excess and incubated at room
temperature overnight with rotation. After labeling, free dye
was removed by a desalting spin column (Pierce), followed by
an additional amylose (NEB) and then NiNTA (Qiagen)
column purification. Efficiently labeled protein yielded an ∼1:1
ratio of fluorophore to protein concentration for a sample,
based on measuring the absorbance at 495 nm (fluorescein, ε =
68,000 M−1 c−1, Thermo Scientific instruction bulletin 0359.2)
or 573 nm (rhodamine, ε = 119,000 M−1 c−1, Molecular Probes
Handbook, 11th edition) in PBS for the dye and 280 nm in 6
M guanidine HCl for the protein. We ensured the applicability
of this metric by testing several samples using analytical HPLC,
indicating free dye had been eliminated and a single population
of labeled protein remained.
Size-Exclusion Chromatography (SEC) Assay. Unla-
beled MBP-SYNZIP proteins were prepared either alone at 10
μM or in pairs at 10 μM each in PBS pH 7.4, 1 mM DTT.
Mixtures were either incubated at room temperature for 2 h or,
for those mixtures with a partner that exhibited homo-
oligomerization, incubated overnight at 37 °C and then cooled
to room temperature for 2 h. Samples (50 μL) were run on a
Waters HPLC system over a Superdex 75 10/300 column (GE
Healthcare) at a flow rate of 0.5 mL/min in PBS pH 7.4, 1 mM
DTT while monitoring absorbance at 215 nm. Empower
software (Waters) was used to analyze the elution profiles. A
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protein,
35 with the sequence RMKQIEDKIEEILSKQYHIE-
NEIARIKKLIGER, which was cloned into the MBP destination
vector described above.
Fluorescence Resonance Energy Transfer (FRET)
Assay. The fluorescence emission of N- and C-terminally
fluorescein-labeled constructs was measured alone and, when
mixed with N-terminally rhodamine-labeled partner, in
triplicate. Samples (100 μL) were mixed at 100 nM
concentration of each protein in PBS pH 7.4, 1 mM DTT,
allowed to incubate 2 h at 37 °C, and then equilibrated 1 h at
room temperature. Samples were excited at 480 nm, and
emission at 525 nm was monitored at 25 °C. Protein
concentrations were determined by the absorbance of the
attached fluorophore in PBS pH 7.4, 1 mM DTT using an
extinction coefficient of 68,000 cm−1 M−1 for fluorescein and
119,000 cm−1 M−1 for rhodamine. Samples were assayed in
384-well black plates (Corning) using a SpectraMax M5 plate
reader (Molecular Devices). The FRET efficiency was
calculated from the average of three samples as
=− FRET efficiency 1
emission
emission
mix
donor
Equilibration of the peptide mixtures was assessed by
remeasuring plates after overnight incubation at 4 °C and re-
equilibration at room temperature for 1 h, which gave no
appreciable change in FRET efficiencies. The antiparallel
heterodimerizing proteins
34 Acid-a1 (AQLEKELQALEKE-
LAQLEWENQALEKELAQ), and Base-a1 (AQLKKKL-
QANKKKLAQLKWKLQALKKKLAQ) were cloned into the
MBP destination vector described above and used as controls.
Fluorescence Polarization (FP) Assay. MBP-SYNZIP
fluoresceinated proteins at 10 nM were mixed with unlabeled
MBP-SYNZIPs at concentrations ranging from 60 pM to 20
μM, depending on the affinity range of the interaction, in PBS
pH 7.4, 1 mM DTT in 384 well black plates (Corning), at a
total volume of 100 μL. The concentrations of all proteins were
determined by measuring absorbance at 280 nm in 6 M
guanidine HCl. Samples were incubated at 37 °C for 2 h and
then allowed to equilibrate at room temperature a minimum of
1 h. Polarization was monitored at 480/525 nm excitation/
emission using a SpectraMax M5 plate reader (Molecular
Devices) at 25 °C. Equilibration of the interactions was
assessed by remeasuring plates after overnight incubation at 4
°C and re-equilibration at room temperature for 1 h, and no
appreciable change in polarization signal was observed. For the
FP competition assay, 20 nM labeled protein was mixed with
each unlabeled partner at 1 μM, incubated at 37 °C for 2 h, and
then equilibrated at room temperature for 1 h before being read
as described above. Raw fluorescence of the labeled protein was
also measured for each well to ensure a constant amount of
labeled protein, and a small number of outliers were removed.
Dissociation constants (Kd's) were determined by curve fitting
using Excel. The average polarization of replicates was
normalized to fraction bound (fb) using the equation
=
−
−
f
SS
SS b
min
max min
where S is the measured signal, Smin is the signal of the lower
baseline, and Smax the upper baseline, selected on the basis of
best fit after multiple curve fitting analyses of the data. Binding
curves were then fit to the equation
=
++ −
f
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where Kd is the dissociation constant, P0 is the initial
concentration of the unlabeled protein, and L0 is the initial
concentration of labeled protein. Kd values were fit using non-
linear least-squares and the Solver plug-in for Excel. In some
cases, the initial fit of the curves to the data was poor, but fits
assuming a lower concentration of the labeled species gave
dramatic improvements. Because of the potential for non-
specific binding of the labeled species to the plastic used in the
assay, it is realistic that the labeled probe concentration might
be lower than 10 nM. Thus, in cases where the fit poorly
matched the data, we fit both the Kd and the labeled species
concentration (within the range 1−10 nM), and in all cases a
lower concentration of labeled species improved the fit to the
data significantly.
Yeast Two-Hybrid Assay. The interaction of SYNZIP
pairs was tested using the ProQuest two-hybrid system
(Invitrogen), in which an interaction reconstitutes Gal4 activity
and drives HIS3 and URA3 expression, allowing identification
of interactions based on growth on selective media.
36,37,47
SYNZIPs fused to the Gal4 activation domain (ADSZs) were
transformed into the yeast strain MaV103; SYNZIPs fused to
the DNA-binding domain of Gal4 (DBDSZs) were transformed
into the strain MaV203 (both strains a gift of M. Vidal). Two
liquid cultures inoculated from single colonies were independ-
ently grown overnight at 30 °C, aliquoted into 96-well plates,
mixed with interaction partners in duplicate from the opposite
mating type, and pin stamped onto YPD plates, resulting in
four replicates in total. After overnight growth at 30 °C,
colonies were replica plated onto synthetic complete media
lacking leucine and tryptophan, to select for yeast carrying both
plasmids, and incubated at 30 °C. Liquid cultures were then
grown overnight, aliquoted into 96-well plates, and pin stamped
onto synthetic complete media either without uracil (high
stringency) or without histidine and with increasing concen-
trations of 3-AT (Sigma) from 10 to 100 mM (low to high
stringency), as well as selection for plasmid maintenance.
Autoactivation controls for both ADSZs and DBDSZs were
performed using the same method without the mating step,
with plating on appropriate dropout media. Colony size was
imaged after 12 days for growth without uracil (-ura) and
without histidine supplemented with 100 mM 3-AT (-his).
CellProfiler
48 was used to determine the area of the colonies,
and analysis of processed image data was performed in Matlab.
To compare the two-hybrid data to the published coiled-coil
array data and to summarize the differences graphically, we
symmetrized the yeast data by taking the stronger of the two
observed interaction signals for pairs that were tested
reciprocally. We binned the 253 resulting pairs into those
that showed strong growth (59 pairs -his, 37 -ura), no growth
(174 pairs -his, 187 -ura), or medium/indeterminate growth
(14 pairs -his, 23 -ura). The indeterminate pairs, as well as 6
additional pairs that involved interactions between two
autoactivators, were excluded from further analyses. The array
results were processed using arrayscores reported by Reinke et
al.,
30 where low scores indicate strong interactions. For the
analysis reported in the text we used a cutoff of arrayscore < 0.6
to identify high-confidence array interactions. A less strict cutoff
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data.
MAPK Pathway Testing. MAPK pathway testing followed
the protocol described by Bashor et al.
9 Msg5-SYNZIP fusions
were integrated into the LEU2 locus of the yeast strain CB011
using a pRS305-derivative vector and expressed with a
constitutive moderate strength promoter from CYC1. These
strains were then transformed a second time with Ste5-
SYNZIPs expressed on a CEN/ARS low copy number pRS316-
derived plasmid driven by the STE5 promoter. Liquid cultures
of dual transformants were grown overnight and then diluted
and grown to an OD600 of ∼0.6. Cultures were treated with 2
μM α-factor, and expression was stopped at 120 min with
cycloheximide at 5 μg/mL. The GFP reporter was allowed to
mature at room temperature for 1 h, and then the mean cell
fluorescence of populations of approximately 10,000 cells was
measured on an LSR II FACS equipped with a high-throughput
sampler using FACSDIVA software (BD Biosciences) followed
by data analysis using FlowJo software (Treestar Inc.). For each
interaction tested, measurements were done in quadruplicate by
picking four initial colonies into separate cultures and
performing the assay for each culture. Because of variability
in the overall scale of the fluorescence signals between days and
strains, signals were corrected for the pre-induction baseline
and also normalized using results for strains with no SYNZIP
fused to Msg5. The following formula was applied
=
−
−
S
SS
SS n
ind basal
indnoSZ basalnoSZ
where Sind is the mean cell fluorescence after 2-h α-factor
induction, Sbasal is mean cell fluorescence before α-factor
induction, and Sind_noSZ and Sbasal_noSZ are the corresponding
post- and pre-induction signals for strains harboring the
appropriate Ste5-SYNZIP along with Msg5 without a SYNZIP
fusion.
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